This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Google, Ford: New Targets, Estimates

Stocks in this article: F GILD GOOG AKS AMG AMZN APC

Also see: Juniper, PetSmart: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

AK Steel (AKS - Get Report) numbers lowered at Goldman. Shares of AKS now seen reaching $12, according to Goldman Sachs. Estimates also cut, as costs continue to rise. Sell rating.

Affiliated Managers Group (AMG - Get Report) estimates, target increased at Citigroup. Shares of AMG now seen reaching $125. Estimates also raised on higher EPS and flow visibility. Buy rating.

Amazon.com (AMZN - Get Report) target raised at Morgan Stanley. Shares of AMZN now seen reaching $275, according to Morgan Stanley. Company continues to see solid sales growth across the board. Overweight rating.

Amazon.com estimates, target adjusted at UBS. Shares of AMZN now seen reaching $215 on accelerating demand, according to UBS. Estimates lowered through 2012. Neutral rating.

Anadarko (APC - Get Report) numbers raised at Goldman. Shares of APC now seen reaching $100. Estimates also increased, given a better exploration outlook. Neutral rating.

Anadarko estimates, target raised at Citigroup. Shares of APC now seen reaching $100. Estimates also raised on heightened catalyst potential and attractive valuation. Buy rating.

Biogen Idec (BIIB) numbers boosted at Jefferies. Shares of BIIB now seen reaching $120. Estimates also upped, given higher Tysabri expectations. Buy rating.

Centene (CNC) estimates, target increased at Goldman. CNC estimates were raised through 2012. Company has a strong growth pipeline. Neutral rating and new $41 price target.

Covidien (COV) estimates, target adjusted at Citigroup. COV price target lowered to $64 on pressure on the peer group's multiple, according to Citigroup. Estimates increased through 2012. Buy rating.

DSW (DSW) estimates, target increased at Citigroup. Shares of DSW now seen reaching $62. Estimates also increased on growth in the leased division and owned units. Buy rating.

Electronic Arts (ERTS) estimates, target raised at UBS. Shares of ERTS now seen reaching $29.50. Estimates also raised on strong pre-orders for important games. Buy rating.

Ford (F - Get Report) estimates lowered at UBS through 2011 to reflect less inventory restocking. Maintain $22 price target and Buy rating.

Gilead (GILD - Get Report) estimates, target upped at Oppenheimer. GILD estimates were boosted through 2012. Company is seeing higher HIV sales. Outperform rating and new $46 price target.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs